Advisornet Financial’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.05K Hold
32
﹤0.01% 1682
2025
Q4
$6.09K Hold
32
﹤0.01% 1684
2025
Q3
$5.3K Buy
+32
New +$5.22K ﹤0.01% 1682
2021
Q4
Sell
-61
Closed -$12K 2023
2021
Q3
$12K Sell
61
-19
-24% -$3.99K ﹤0.01% 1396
2021
Q2
$16K Sell
80
-600
-88% -$112K ﹤0.01% 1295
2021
Q1
$119K Hold
680
0.01% 703
2020
Q4
$115K Hold
680
0.01% 649
2020
Q3
$110K Hold
680
0.01% 642
2020
Q2
$111K Buy
680
+80
+13% +$12.2K 0.01% 640
2020
Q1
$77K Hold
600
0.01% 673
2019
Q4
$84K Hold
600
0.01% 732
2019
Q3
$71K Hold
600
0.01% 782
2019
Q2
$77K Hold
600
0.01% 681
2019
Q1
$77K Hold
600
0.01% 625
2018
Q4
$66K Buy
+600
New +$72.5K 0.01% 616

Other funds holding BBH

Advisornet Financial's BBH Position: Q1 2026 in Review

Advisornet Financial held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 32 shares worth $6.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1682.

Advisornet Financial first reported a position in BBH in Q4 2018 and has held it in 15 quarters since. The position peaked at $119K in Q1 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Advisornet Financial held 32 shares of VanEck Biotech ETF worth $6.05K as of Q1 2026.
  • Advisornet Financial left its VanEck Biotech ETF share count unchanged in Q1 2026.
  • VanEck Biotech ETF made up ﹤0.01% of Advisornet Financial's portfolio in Q1 2026, its #1682 holding.
  • Advisornet Financial first reported a position in VanEck Biotech ETF in Q4 2018 and has held it in 15 quarters since.
  • Advisornet Financial's VanEck Biotech ETF position peaked at $119K in Q1 2021.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Advisornet Financial's 13F filing for Q1 2026, filed 17 Apr 2026.